Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-882-6 | CAS number: 928771-01-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- UK Department of Health, 21 November 2005
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- NEXBTL renewable diesel
- IUPAC Name:
- NEXBTL renewable diesel
- Details on test material:
- - Name of test material (as cited in study report): NExBTL Biodiesel
- Description: Clear colourless liquid
- Date received: 04 July 2006
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: human
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Adult male Sprague Dawley rat liver S9 fraction (induced with three consecutive daily doses of 80 mg/kg bw/d phenobarbitone, 100 mg/kg bw/d B-naphthoflavone)
- Test concentrations with justification for top dose:
- Following test concentrations used (based on preliminary cytotoxicity test ): 0, 312.5, 65, 1250 and 2500 ug/ml
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: based on earlier solubility tests (reported in endpoint study record Genetic Toxicity in vitro.001)
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: mitomycin c (-S9); cyclophosphamide (+S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
- In Minimal Essential Medium with duplicate cultures prepared per exposure concentration for each of two independent experiments
NUMBER OF EXPERIMENTS:
- 2 independent repeats
DURATION:
- Preincubation period: 48 hr (to establish primary culture)
- Exposure duration: 4 hr, hower in experiment 2 in incubations in the absence of S9 fraction exposure was continuous for 24 hr
- Expression time (cells in growth medium): experiment 1 (+/- S9) 20 hr; experiment 2 (+S9 only) 20 hr
SPINDLE INHIBITOR (cytogenetic assays):
- Colcemid 0.1 ug/ml (2 hr before harvest)
STAIN (for cytogenetic assays):
- 5% Gurs Giemsa
MITOTIC INDEX:
- 2000 lymphocyte cell nuclei were counted and the number of cells in metaphase recorded; expressed as the mitotic index and as a percentage of the control value.
NUMBER OF CELLS EVALUATED FOR CHROMOSOME DAMAGE:
_ The first 100 consecutive well-spread metaphases from each culture were counted. Slides were coded and scored blind.
DETERMINATION OF CYTOTOXICITY:
- Method: cells were exposed to 9 concentrations of test substance in the range 19.53 - 5000 ug/ml for 4 hr with and without metabolic activation followed by a 20 hr expression period; in one trial without S9 fraction cells received a continuous 24 hr exposure. Mitotic index data were used to estimate cytotoxicity.
OTHER EXAMINATIONS:
- Precipitate observations were performed over the concentration range 19.53 - 5000 ug/ml. An oily precipitate was observed at 1250 ug/ml and above but this was not cytotoxic.
POSITIVE CONTROLS:
- absence of S9 fraction: mitomycin c in Minimal Essential Medium (0.4 ug/ml and 0.2 ug/ml for experiments 1 and 2, respectively)
- presence of S9 fraction: cyclophosphamide in DMSO (4 and 5 ug/ml for experiments 1 and 2, respectively) - Evaluation criteria:
- Breaks, gaps and rearrangements were noted according to:
- the International System for Chromosome Nomenclature (1985), ed Harnden, DG et al., Karger, Switzerland
- Savage, JRK (1976) Annotation: classification and relationships of induced chromosomal structural changes. J Med Genet 13, 103-122
- Scott, D et al. (1990) Metaphase chromosome aberration assays in vitro. In: Basic mutagenicity tests - UKEMS recommended procedures, Kirkland DJ, ed. Cambridge University Press - Statistics:
- Frequency of cells with aberrations excluding gaps and the frequency of polyploid cells was compared with concurrent control values using Fisher's Exact test.
Results and discussion
Test results
- Species / strain:
- lymphocytes:
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- CYTOTOXICITY:
- The test substance demonstrated no evidence of cytotoxicity in any of the exposure groups.
STUDY RESULTS:
- No increase in the frequency of cells with aberrations or the incidence of polyploidy was recorded in either experiment in the absence or presence of S9 fraction, up to the maximum dose tested (2500 ug/ml).
POSITIVE CONTROLS:
- A satisfactory response was obtained with the positive control substances in both experiments. - Remarks on result:
- other: strain/cell type: human lymphocytes
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
Not clastogenic in human lymphocytes in the absence or presence PB/B-NF-induced rat S9 fraction. - Executive summary:
Clastogenic potential was assessed in a GLP-compliant guideline study (method B10 of directive 2004/73/EC). Based on results obtained from an initial cytotoxicity screen, test concentrations of 312.5-2500 ug/ml were used in the absence and in the presence of phenobarbitone/B-naphthaflavone induced rat S9 fraction, and the study run using 2 independent repeats. An oily precipitate was observed at 1250 ug/plate and above, but this was not cytotoxic. No increase in the frequency of cells with aberrations or the incidence of polyploidy was recorded in two independent experiments in the absence or presence of S9 fraction, up to the maximum dose tested (2500 ug/ml). A satisfactory response was obtained with the positive control substances (-S9 mitomycin c; +S9 cyclophosphamide) in both experiments. The results indicate that NExBTL renewable diesel is not clastogenic to human lymphocytes in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
På den här webbplatsen används kakor. Syftet är att optimera din upplevelse av den.